Home > Search Results: Márquez-Malaver, F.J.
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 4 records in 0.01 seconds.
Articles, 4 records found
Articles 4 records found  
1.
8 p, 894.2 KB Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma / Kekre, N. (The Ottawa Hospital) ; Marquez-Malaver, Francisco J. (Instituto de Biomedicina de Sevilla) ; Cabrero, Monica (Instituto Biosanitario de Salamanca (IBSAL)) ; Piñana, J. (Hospital Clínic Universitari (València)) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Soiffer, Robert J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Caballero, Dolores (Instituto Biosanitario de Salamanca (IBSAL)) ; Terol, M.J. (Hospital Clínic Universitari (València)) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Antin, Joseph H. (Harvard Medical School) ; Lopez-Corral, L. (Instituto Biosanitario de Salamanca (IBSAL)) ; Solano, Carlos (Hospital Clínic Universitari (València)) ; Armand, Philippe (Harvard Medical School) ; Pérez-Simon, Jose A. (Instituto de Biomedicina de Sevilla) ; Universitat Autònoma de Barcelona
There is at present little data to guide the choice of conditioning for patients with lymphoma undergoing reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (SCT). In this study, we compared the outcomes of patients undergoing RIC SCT who received fludarabine and melphalan (FluMel), the standard RIC regimen used by the Spanish Group of Transplantation, and fludarabine and busulfan (FluBu), the standard RIC regimen used by the Dana-Farber Cancer Institute/Brigham and Women's Hospital. [...]
2016 - 10.1016/j.bbmt.2016.07.006
Biology of blood and marrow transplantation, Vol. 22 Núm. 10 (january 2016) , p. 1808-1815  
Detailed record - Creative Commons
2.
25 p, 635.6 KB CD34 + Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome / Barba, Pere (Hospital Universitari Vall d'Hebron) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Zhou, Qin (Memorial Sloan Kettering Cancer Center) ; Cho, Christina (Weill Cornell Medical College) ; Castro-Malaspina, Hugo (Weill Cornell Medical College) ; Devlin, Sean M (Memorial Sloan Kettering Cancer Center) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Giralt, Sergio (Weill Cornell Medical College) ; Jakubowski, Ann A. (Weill Cornell Medical College) ; Caballero, Dolores (Hospital Universitario Salamanca (CAUSA/IBSAL)) ; Maloy, Molly (Memorial Sloan Kettering Cancer Center) ; Papadopoulos, Esperanza B. (Weill Cornell Medical College) ; Piñana, José Luis (Hospital Clínic Universitari (València)) ; Fox, Maria Laura (Hospital Universitari Vall d'Hebron) ; Márquez-Malaver, Francisco J. (Hospital Virgen del Rocío Sevilla) ; Valcárcel, David (Hospital Universitari Vall d'Hebron) ; Solano, Carlos (Hospital Clínic Universitari (València)) ; López-Corral, Lucía (Hospital Universitario Salamanca (CAUSA/IBSAL)) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Perales, Miguel-Angel (Weill Cornell Medical College) ; Universitat Autònoma de Barcelona
Reduced-intensity conditioning (RIC) and T cell depletion (TCD) through CD34 cell selection without the use of post-transplantation immunosuppression are 2 strategies used to reduce nonrelapse mortality (NRM) in older patients after allogeneic hematopoietic cell transplantation (allo-HCT). [...]
2018 - 10.1016/j.bbmt.2017.12.804
Biology of blood and marrow transplantation, Vol. 24 Núm. 5 (may 2018) , p. 964-972  
Detailed record - Creative Commons
3.
8 p, 930.0 KB Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study / Escamilla Gómez, V. (Universidad de Sevilla) ; García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ; López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ; Márquez Malaver, F.J. (Universidad de Sevilla) ; Caballero Velazquez, Teresa (Universidad de Sevilla) ; González Sierra, P.A. (Hospital Universitario (Granada)) ; Viguria Alegría, M.C. (Complejo Hospitalario de Navarra) ; Parra Salinas, I.M. (Hospital Universitario Miguel Servet (Saragossa)) ; Calderón Cabrera, C. (Universidad de Sevilla) ; González Vicent, M. (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Rodríguez Torres, N. (Universidad de Sevilla) ; Parody Porras, R. (Instituto Catalá de Oncología Hospitalet) ; Ferrá, Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Orti, Guillermo (Hospital Universitari Vall d'Hebron) ; Valcárcel Ferreiras, D. (Hospital Universitari Vall d'Hebron) ; de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ; Molés, P. (Hospital Universitari i Politècnic La Fe (València)) ; Velázquez-Kennedy, K. (Hospital Universitari Ramon y Cajal) ; João Mende, M. (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Caballero, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Saavedra Gerosa, Silvana Daniela (Institut d'Investigació Biomèdica Sant Pau) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Poch, M. (Clinic Hospital Universitari de Valencia) ; Zudaire Ripa, M.T. (Complejo Hospitalario de Navarra) ; Díaz Pérez, M.A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Molina Angulo, B. (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Sánchez Ortega, I. (Instituto Catalá de Oncología Hospitalet) ; Sanz Caballer, J. (Hospital Universitari i Politècnic La Fe (València)) ; Montoro Gómez, J. (Hospital Universitari i Politècnic La Fe (València)) ; Espigado Tocino, I. (Universidad de Sevilla) ; Pérez-Simón, J.A. (Universidad de Sevilla) ; Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648  
Detailed record - Creative Commons
4.
8 p, 906.3 KB Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia : A Retrospective Analysis from the Time of Transplant Approval / Rodríguez-Arbolí, Eduardo (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Márquez-Malaver, F. J. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Rodríguez-Torres, N. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Caballero Velazquez, Teresa (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Escamilla-Gómez, V. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Calderón Cabrera, C (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Falantes-González, J. F. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Solé-Rodríguez, M. (Hospital Juan Ramón Jiménez (Huelva)) ; García-Ramírez, P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Moya-Arnao, María (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Espigado, Ildefonso (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Pérez-Simón, José Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Universitat Autònoma de Barcelona
Clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-SCT) from unrelated donors (URDs) approach those of matched related donor (MRD) transplants in patients with acute myeloid leukemia (AML). [...]
2019 - 10.1016/j.bbmt.2018.08.019
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 183-190  
Detailed record - Creative Commons

See also: similar author names
2 Marquez-Malaver, Francisco J.
1 Márquez-Malaver, F. J.
2 Márquez-Malaver, Francisco J.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with